Moderna invoices 6300 percent extra 2021 financial year as the biotechnological enters 4,400 million dollars, and 4,200 correspond to the vaccine.
After reaching its first profitable quarter in history, Modern enters this second quarter 4.354 million dollars (about 3.672 million euros at the current exchange rate), compared to $ 66 million in the same period of 2020 (55 million euros) and the 13 million (nearly 11 million), 2019.
Of these, the biotechnologist has obtained a net income of 2,800 million dollars or 2,361 million euros at the current exchange rate.
Moderna's growth is 6,392.5% above the results obtained in the second quarter of the previous year and more than 2,300% of the results of the first quarter profitable since its foundation —when it entered 1,900 million dollars (more than 1,582 million euros).
"I am proud of the progress our teams at Moderna have made in the last quarter in advancing our development line while addressing a global pandemic and rapidly establishing global manufacturing and commercial organizations," said Stéphane Bancel, CEO of Moderna.
Moderna invoices 6300 percent extra 2021 financial year
For their part, analysts expected that the pharmaceutical-at the head of one of the vaccines developed against COVID— 19 and based on the promising messenger RNA technology-would enter 4,290 million dollars (3,618 million euros), 6,368% with respect to the quarter of the previous year.
And, despite being record figures that show the boost that the COVID-19 vaccine has given to the biotechnology business, it has exceeded the expectations of analysts.
In terms of earnings per share, analysts expected the biotech company's figure to be between $ 5.96 (Wall Street) and $ 6.46 (according to Investopedia), compared to losses of $ 0.31 per share in the second quarter of 2020.
Moderna invoices 6300 percent extra 2021 financial year
Along the same lines, Moderna has declared earnings per share of exactly $ 6.46 —after skyrocketing 231% to date, according to NASDAQ (US stock index).
Now, for the fiscal year, earnings per share are estimated to be between $ 24.57 (NASDAQ) and $ 26.17 (Wall Street), compared to $ -1.96 in 2020.
While waiting to enter 23 times more turnover in the entire previous year, the present 18.770 million dollars (15.830 million euros) compared to 803 million (approximately 677 million euros at current exchange).
Moderna invoices 6300 percent extra 2021 financial year
Revenue from the vaccine has obviously grown at a dizzying pace.
This second quarter the sales of the vaccine amount to 4,197 million dollars (3,539 million euros) of the 4,354 million dollars (about 3,672 million euros at the current exchange rate) total—when in the first 3 months of this fiscal year it billed about 1,733 million dollars in vaccines (about 1,443 million euros) of the 1,900 total revenues—.
By then, Moderna had again raised the delivery forecast of its developed COVID-19 vaccine by 2021 to between 800 million and 1 billion doses —Pfizer estimates that it will deliver 2.1 billion injections in 2021.
Moderna invoices 6300 percent extra 2021 financial year
"The team and our manufacturing partners are working hard to get as close as possible to 1 billion doses by 2021," encouraged its CEO, Stéphane Bancel.
The same is maintained after the presentation of the 3 months due in June. But it advances that it will amount to between 2,000 million (of 100 µg) and 3,000 million vials (if it is 50 µg) in 2022.
The numbers may vary if the vaccine is approved for new age ranges. Also if ongoing research concludes that booster doses are needed to curb the new variants of the coronavirus.
However, Bancel highlighted in the presentation that the vaccine is demonstrating a lasting efficacy of 93% for at least 6 months. While recognizing that the delta variant is a major new threat, they must remain vigilant.
Moderna invoices 6300 percent extra 2021 financial year
More news:
Movistar and Orange agree to reorganize frequencies in the 3.5 GHz band in an important step for the deployment of 5G
The rearrangement of the 3.5 GHz band was a pending issue for the current Government. Now, according to Expansión, Movistar and Orange have reached a crucial agreement to reorganize their frequencies in this band, a fundamental step in the deployment of the 5G network.
Until now, mobile operators had acquired different blocks in the auctioned frequencies for the 5G. However, these processes resulted in a consequence that hides some obstacles for the operators, since in most cases they did not have their contiguous blocks. In fact, the only one that had a single block so far was Vodafone.
Now the strategic agreement between Orange and Movistar reorganizes those blocks within the 3.5 GHz band —which actually occupies from 3.4 GHz to 3.8 GHz— which in turn will benefit MásMóvil and, more indirectly, Vodafone.
Why is it important to have the contiguous blocks within the band? As Expansión explains, it allows you to add the different coverage bands and offer the maximum connection speed.
The best example is the case of Vodafone, which already had a good part of the contiguous spectrum in the 3.7 GHz band, since July 2018. That made it easier for the company to commercially launch 5G services before the competition. ” If the spectrum is divided into different blocks, certain attributes such as maximum speed or capacity are reduced, " Julia Velasco, Network Director of Vodafone Spain, explained months ago.
Movistar and MásMóvil would remain under this agreement with the low zone of the 3.5 GHz band, fundamental for the deployment of the 5G, while Orange and Vodafone would remain in the highest part. For these last two companies the movement is especially important due to the Jumping agreement, an alliance they have woven to integrate their networks in populations of less than 175,000 inhabitants to reduce costs. In addition, he underlines the economic environment, the reorganization would facilitate a much more ambitious integration between the networks of both companies that could reach the entire national territory.
The agreement comes shortly after it is known that the Government has reserved part of the 2.3 GHz band so that all kinds of private companies can develop their own 5G networks to self-provide services outside the operators. Something that Movistar, Vodafone and Orange see as a threat to their sector because, they understand, it can mean the loss of million-dollar contracts with large companies that choose to develop their own internal networks.
The Ministry of Economic Affairs and Digital Transformation expects that by 2025 75% of the population will have 5G coverage.